logo
  

FMC Technologies Q1 Profit Rises - Quick Facts

FMC Technologies Inc. (FTI) reported that its first-quarter net income attributable to company increased to $135.2 million or $0.57 per share, from $102.4 million or $0.43 per share, previous year.

On average, 29 analysts polled by Thomson Reuters expected the company to report profit per share of $0.50 for the quarter. Analysts' estimates typically exclude special items.

Revenue increased to $1.82 billion from $1.65 billion. Analysts expected revenue of $1.80 billion for the quarter.

Total inbound orders were $2.6 billion and included $1.9 billion in Subsea Technologies orders. The company's backlog stands at $7.8 billion, including Subsea Technologies backlog of $6.8 billion.

"As a result of strong orders in the quarter, Subsea Technologies achieved record backlog. We delivered solid subsea revenue and operating profit and expect to see this trend continue throughout the remainder of the year," said John Gremp, Chairman, President and CEO of FMC Technologies.

The company's guidance for 2014 earnings per share is $2.55 to $2.75, but now excludes both the expected results from operations of the material handling products business post divestiture and an anticipated gain associated with the sale. Analysts expect the company to report 2014 profit per share of $2.65.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

First quarter growth data from China gained the maximum focus this week as trends in the massive emerging economy impact its trading partners. Elsewhere, the IMF released its latest global macroeconomic projections. Read our story to find out why comments from the Fed Chair Powell damped rate cut expectations. Meanwhile, there was some survey data that kindled hopes of a recovery in manufacturing. In the U.K., inflation data for March revealed some confusing trends.

View More Videos
RELATED NEWS
Follow RTT